ATP citrate-lyase

CAT # Magaca Alaabta Sharaxaada
CPD3611 SB-204990 SB-204990 waa soosaarayaasha awoodda leh ee ATP citrate-lyase inhibitor SB-201076. SB-204990, marka afka laga qaato jiirka, ayaa lagu nuugay wareegga nidaamka, fiirsashada dawooyinka ee SB-201076 ayaa laga soo kabsaday beerka. SB-204990 (25 mg/kg maalintii) ayaa sidoo kale hoos u dhigtay heerarka kolestaroolka plasma (ilaa 23%) iyo heerarka triglyceride (ilaa 38%) ee eyga, oo doorbidaya hoos u dhigista lipoprotein hoose marka la barbar dhigo kolestaroolka sare ee lipoprotein heerarka. SB-204990 waa enzym muhiim ah oo lagu xakameynayo sahayda substrate ee isku dhafka lipid de novo iyo bartilmaameedka suurtagalka ah ee enzyme ee faragelinta hypolipidaemic.
oo

Nala Soo Xidhiidh

Weydiin

Wararkii Ugu Dambeeyay

  • 7-da Isbeddel ee ugu Sarreysa ee Cilmi-baarista Dawooyinka 2018

    7-da Isbeddel ee ugu Sarreysa Cilmi-baarista Dawooyinka Waxaan...

    Iyadoo lagu jiro cadaadis sii kordhaya si loogu tartamo jawi dhaqaale iyo teknoloji oo adag, shirkadaha dawooyinka iyo bayoolojiga waa inay si joogto ah u cusbooneysiiyaan barnaamijyadooda R&D si ay horay ugu sii socdaan ...

  • ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay kansarka-KRAS-mutant

    ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay K...

    Sida laga soo xigtay cilmi-baaris lagu daabacay Cell, cilmi-baarayaashu waxay sameeyeen xannibaado gaar ah oo loogu talagalay KRASG12C oo loo yaqaan ARS-1602 taas oo keentay dib u noqoshada buro ee jiirarka. "Daraasaddani waxay ku siinaysaa caddayn vivo ah in KRAS mutant uu noqon karo ...

  • AstraZeneca waxay heshaa kor u qaadida sharciyeynta ee daawooyinka kansarka

    AstraZeneca waxay heshay kor u qaadida sharciyeynta ee...

    AstraZeneca waxay heshay labanlaab kor u qaadis ah faylalka Oncology Talaadadii, ka dib markii sharciyeeyayaasha Mareykanka iyo Yurub ay aqbaleen soo gudbinta sharciyeynta dawooyinkeeda, tallaabada ugu horreysa ee lagu guuleysto oggolaanshaha daawooyinkan. ...

WhatsApp Online chat!